{
    "organizations": [],
    "uuid": "43e2f31abcaf01d3e6c4d5f8aa3c107922ebc85c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-swedish-orphan-biovitrum-says-rece/brief-swedish-orphan-biovitrum-says-receives-positive-opinion-from-chmp-on-anakira-idUSFWN1QD1BZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Swedish Orphan Biovitrum says receives positive opinion from CHMP on Anakira",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 23 (Reuters) - Swedish Orphan Biovitrum Ab (Publ) says:\n* The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Anakinra for the treatment of Stillâ€™s disease.\n* The opinion is now referred to the European Commission for a decision. Source text for Eikon: Further company coverage: (Reporting By Johan Sennero)\n ",
    "published": "2018-02-23T23:00:00.000+02:00",
    "crawled": "2018-02-24T13:38:13.029+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "swedish",
        "orphan",
        "biovitrum",
        "ab",
        "publ",
        "say",
        "committee",
        "medicinal",
        "product",
        "human",
        "use",
        "chmp",
        "european",
        "medicine",
        "agency",
        "ema",
        "adopted",
        "positive",
        "opinion",
        "anakinra",
        "treatment",
        "still",
        "disease",
        "opinion",
        "referred",
        "european",
        "commission",
        "decision",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "johan",
        "sennero"
    ]
}